Mode
Text Size
Log in / Sign up
N/A N=80 Randomized Double-blind Treatment

Emotion Regulation and Emotion Perception

Emotions

Enrolled (actual)
80
Serious AEs
0.0%
Results posted
Feb 2021
Primary outcome: Primary: The Ability to Perceive Negative and Positive Emotional Expressions, as Measured by a Behavioral Computer-based Assessment — 77.31; 81.93; 84.85 Percent of correct responses — p=0.018

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Mindful Breathing (Behavioral); Habituation (Behavioral); Control (Behavioral)
Age
Adult · 18+ yrs
Sex
All
Sponsor
Duke University
Primary completion
Dec 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
The Ability to Perceive Negative and Positive Emotional Expressions, as Measured by a Behavioral Computer-based Assessment
77.31; 81.93; 84.85 0.018 sig
PRIMARY
Changes in Emotion Perception, as Measured by a Phone-based Behavioral Assessment
5.19; 5.3; 5.23 0.396
SECONDARY
Change in Emotional Distress, as Measured by Subjective Units of Distress (SUDS)
1.14; 0.61; 0.56 0.002 sig

Summary

The purpose of this study is to assess the impact of a brief, emotion regulation intervention on the ability to perceive other people's emotions.

Eligibility Criteria

Inclusion Criteria

  • ages 18-55;
  • have a smartphone and agree to receive text-messages;
  • have difficulty with their relationships or social interactions;
  • high emotion dysregulation, assessed with the Difficulties with Emotion Regulation Scale (DERS)(Gratz & Roemer, 2004) with scores over 90.

Exclusion Criteria

  • Current mania;
  • Meets full criteria for any current psychotic disorder;
  • Currently/chronically homeless;
  • Current suicidal ideation;
  • Psychiatric hospitalization within past 6 months;
  • Unable to read, blind or deaf. Our previous study recruited only participants who were currently in treatment, but this study will include both participants who are currently in treatment, as well as those who are not in treatment.
  • high self-reported autistic traits, as assessed by the Autism Spectrum Quotient (Auyeung & Baron-Cohen, 2012).
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03790878). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search